InvestorsHub Logo
Followers 34
Posts 2986
Boards Moderated 0
Alias Born 02/27/2016

Re: None

Saturday, 10/01/2016 9:39:04 AM

Saturday, October 01, 2016 9:39:04 AM

Post# of 457211
At this point, even if our next data release on the Alz trial is lackluster, it will do little to affect the share price. I don't think it is likely to reveal anything definitive anyway. We are already priced as if it was a failure. We know that we are currently collecting data to drive a successful phase 3. Missling is not worried about the interim price fluctuations and neither should we.

Time is of the essence for Biogen and BP. Missling is negotiating from strength.

The ugly girl in the room just got asked to dance by one of the jocks. Everyone is wondering why, and kicking themselves for not doing it first. She just took off her glasses and is about to let down her hair. Now they all want a piece. What will she do?
Volume:
Day Range:
Bid:
Ask:
Last Trade Time:
Total Trades:
  • 1D
  • 1M
  • 3M
  • 6M
  • 1Y
  • 5Y
Recent AVXL News